REDWOOD CITY, Calif. (AP) _ AcelRx Pharmaceuticals Inc. (ACRX) on Wednesday reported a loss of $13.7 million in its first quarter.
The Redwood City, California-based company said it had a loss of 17 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
The drugmaker posted revenue of $265,000 in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $845,000.
In the final minutes of trading on Wednesday, the company's shares hit $3.51. A year ago, they were trading at $2.50.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRX at https://www.zacks.com/ap/ACRX